Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Wave Life Sciences
WVE
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent at other companies
Ionis Pharmaceuticals
IONS
-24.7%
-5.0pp
Other financials
Income statement
See full
Revenue
$38.2M
+317%
Operating income
-$31.3M
+37.2%
Net income
-$26.1M
+44.4%
EPS (diluted)
-$0.13
+55.2%
Balance sheet
See full
Cash & equivalents
$544.6M
+124%
Total debt
$15.7M
-33.4%
Total equity
$511.7M
+198%
Total assets
$583.5M
+102%
Cash flow
See full
Operating cash flow
-$59.6M
+5.5%
CapEx
$438.0K
+165%
Free cash flow
-$60.0M
+5.1%
Valuation
See full
Market cap
$1.11B
+9.2%
Enterprise value
$577.44M
-27.2%
P/S
14.6×
-11.8×
Profitability
See full
Operating margin
-75.7%
-33.6pp
Net margin
-66.5%
-29.9pp
FCF margin
-27.2%
-12.6pp
Returns & leverage
See full
Return on equity
-53.7%
—
Debt / equity
0×
-0.1×
Current ratio
11.3×
+8.3×